©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 28, 2014; 20(8): 1910-1922
Published online Feb 28, 2014. doi: 10.3748/wjg.v20.i8.1910
Published online Feb 28, 2014. doi: 10.3748/wjg.v20.i8.1910
Table 1 Chemotherapy regimen in locally advanced and metastatic colon cancer
| No. | Regimen | Dosing | Frequency | Adjuvant | Palliative |
| 1 | 5-FU/LV | Leucovorin 400 mg/m2 IV over 2 h before 5-FU on day 1 | Every 2 wk | Y | Y |
| 5-FU 400 mg/m2 IV bolus on day 1, followed by 2400 mg/m2 IV over 46 h | |||||
| 2 | Capecitabine | Capecitabine 1000-1250 mg/m2 by mouth twice daily for 2 wk, then 1 wk off | Every 3 wk | Y | Y |
| 3 | FOLFOX | Leucovorin 400 mg/m2 IV over 2 h before 5-FU on day 1 | Every 2 wk | Y | Y |
| 5-FU 400 mg/m2 IV bolus on day 1, followed by 2400 mg/m2 IV over 46 h | |||||
| Oxaliplatin 85 mg/m2 IV on day 1 | |||||
| 4 | CAPOX | Capecitabine 850-1000 mg/m2 by mouth twice daily for 2 wk, then 1 wk off | Every 3 wk | Y | Y |
| Oxaliplatin 130 mg/m2 IV on day 1 | |||||
| 5 | FOLFIRI | Leucovorin 400 mg/m2 IV over 2 h before 5-FU on day 1 | Every 2 wk | N | Y |
| 5-FU 400 mg/m2 IV bolus on day 1, followed by 2400 mg/m2 IV over 46 h | |||||
| Irinotecan 180 mg/m2 IV over 90 min on day 1 | |||||
| 6 | FOLFOX + Bevacizumab | Leucovorin 400 mg/m2 IV over 2 h before 5-FU on day 1 | Every 2 wk | N | Y |
| 5-FU 400 mg/m2 IV bolus on day 1, followed by 2400 mg/m2 IV over 46 h | |||||
| Oxaliplatin 85 mg/m2 IV on day 1 | |||||
| Bevacizumab 5 mg/kg IV on day 1 | |||||
| 7 | FOLFIRI + Bevacizumab | Leucovorin 400 mg/m2 IV over 2 h before 5-FU on day 1 | Every 2 wk | N | Y |
| 5-FU 400 mg/m2 IV bolus on day 1, followed by 2400 mg/m2 IV over 46 h | |||||
| Irinotecan 180 mg/m2 IV over 90 min on day 1 | |||||
| Bevacizumab 5 mg/kg IV on day 1 | |||||
| 8 | CAPOX + Bevacizumab | Capecitabine 850-1000 mg/m2 by mouth twice daily for 2 wk, then 1 wk off | Every 3 wk | N | Y |
| Oxaliplatin 130 mg/m2 IV on day 1 | |||||
| Bevacizumab 7.5 mg/kg IV on day 1 | |||||
| 9 | Capecitabine + Bevacizumab | Capecitabine 850-1000 mg/m2 by mouth twice daily for 2 wk, then 1 wk off | Every 3 wk | N | Y |
| Bevacizumab 7.5 mg/kg IV on day 1 | |||||
| 10 | 5-FU/LV + Bevacizumab | Leucovorin 400 mg/m2 IV over 2 h before 5-FU on day 1 | Every 2 wk | N | Y |
| 5-FU 400 mg/m2 IV bolus on day 1, followed by 2400 mg/m2 IV over 46 h | |||||
| Bevacizumab 5 mg/kg IV on day 1 | |||||
| 11 | FOLFIRI + Cetuximab | Leucovorin 400 mg/m2 IV over 2 h before 5-FU on day 1 | Every 2 wk | N | Y |
| 5-FU 400 mg/m2 IV bolus on day 1, followed by 2400 mg/m2 IV over 46 h | |||||
| Irinotecan 180 mg/m2 IV over 90 min on day 1 | |||||
| Cetuximab 400 mg/m2 IV loading on treatment day 1, then 250 mg/m2 IV every week | |||||
| 12 | FOLFIRI + Ablifercept | Leucovorin 400 mg/m2 IV over 2 h before 5-FU on day 1 | Every 2 wk | N | Y |
| 5-FU 400 mg/m2 IV bolus on day 1, followed by 2400 mg/m2 IV over 46 h | |||||
| Irinotecan 180 mg/m2 IV over 90 min on day 1 | |||||
| Aflibercept 4 mg/kg, over 1 h on day 1 | |||||
| 13 | Panitumumab | Panitumumab 6 mg/kg IV | Every 2 wk | N | Y |
| 14 | Regorafenib | Regorafenib 160 mg by mouth once daily for 3 wk, then 1 wk off | Every 4 wk | N | Y |
- Citation: Kurniali PC, Hrinczenko B, Al-Janadi A. Management of locally advanced and metastatic colon cancer in elderly patients. World J Gastroenterol 2014; 20(8): 1910-1922
- URL: https://www.wjgnet.com/1007-9327/full/v20/i8/1910.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i8.1910